Primer on Tumor Immunology

Program Schedule

8:00 am-8:40 am
Anti-idiotype Vaccines
Daniel P. Gold, PhD
8:40 am-9:20 am
Dendritic Cells
James J. Mulé, PhD
9:20 am-10:00 am
Transgenic Class I
Elizabeth A. Repasky, PhD
10:00 am-10:15 am
Break
10:15 am-10:55 am 
T Cell Antigen Identification
Alessandro Sette, PhD
10:55 am-11:40 am
T Cell Specific Ligands
Darcy B. Wilson, PhD
11:40 am-12:40 pm
Lunch
12:40 pm-1:20 pm
Chimeric Immune Molecules
Ralph Reisfeld, MD
1:20 pm-2:00 pm
Antibody Engineering
Anna M. Wu, PhD
2:00 pm-2:40 pm
DNA Vaccines
Thomas Kipps, MD, PhD
2:40 pm-3:00 pm
Break
3:00 pm-3:40 pm
Antigen Discovery
Mitchell Reff, PhD
3:40 pm-4:20 pm
T Cell Therapies
Laurence J.N. Cooper, MD, PhD
4:20 pm-5:00 pm
Point Counter-Point
What is the Best Form(s) of Antigen for Cancer Vaccine Approaches
James J. Mulé, PhD
Jeffrey S. Weber, MD, PhD